Share this project and help them succeed!
In Situ Global Clinical Trials Network, LLC was founded in March 3rd, 2016, and since then has developed into a robust, comprehensive cooperative of twenty-four (24) United States Board-Certified Specialist and Subspecialist physicians on ten (10) clinical specialties prepared to address the specific challenges of Hispanic participation in clinical trials. Based in Puerto Rico, our physicians network englobes the Island, which encompasses a 3.5 million inhabitants population in a 3,500 square miles United States of America territory.
Now, our primary goal is to insert in the global industry-sponsored clinical trials pipeline, and our secondary goal is to integrate physicians on ten (10) more clinical specialties to further increase our clinical trials participation opportunities.
You are welcome to learn more about In Situ Global Clinical Trials Network, LLC at http://www.insitu.global.
Longstanding Hispanic clinical issues such as poor pharmacological response, polypharmacy, varied metabolism rates, and intricate genetic makeups inevitably force the question about the applicability of clinical results to this population group, specially in light of its low degree of participation in clinical trials. In Situ Global Clinical Trials Network, LLC strives to promote Hispanic patient participation in clinical trials by providing an engaging clinical, educational, and cultural platform, tethered to comprehensive logistics.
Hispanics patients interested in contributing to clinical trials through In Situ Global Clinical Trials Network, LLC will encounter a physician-based, patient-centered structure with a highly qualified and relatable Hispanic staff, dedicated to valuing and developing their participation in a fluent manner.
The reality of the modern-day United States of America population demands the participation of both Hispanic patients and physicians. Therefore, In Situ Global Clinical Trials Network, LLC has been developed to support physicians on all administrative and logistics aspects of conducting industry-sponsored trials, thus allowing for their sole focus on clinical matters. Nevertheless, the relief of these bureaucratic affairs does not isolate physicians and clinical staff from corporate affairs, as all network decisions are open to the consideration of its entire membership prior to any action, allowing for a transparent and absolutely representative executive management. At In Situ Global Clinical Trials Network, LLC, Hispanic patients and physicians contribute to clinical trials, and help generate more effective biomedical products and processes, within a professional environment characterized by openness, collaborations, and efficiency.
Needless to say, Hispanic physicians participating in clinical trials are not only able to provide an additional clinical alternative for a segment of their patient population, but also become part of a unique professional experience. Collaborating in the development of a groundbreaking clinical product is a medical honor and a deep personal satisfaction.
In Situ Global Clinical Trials Network, LLC was created to address the dire need of both Hispanic patients and physicians in clinical trials, and their contrasting reasons for nonparticipation. While Hispanic patients question the motivations for their invitation to participate in clinical trials, Hispanic physicians often deem clinical trials an administratively and logistically bureaucratic activity that will ultimately affect any regular clinical practice.
Since its creation, In Situ Global Clinical Trials Network, LLC continuously searches for ways to advance its professional offerings, while incorporating resources that will facilitate the overall conduction of a clinical trial. Partners of In Situ Global Clinical Trials Network, LLC can expect the dedicated collaboration of a collective of experienced and highly regarded professionals that will strive to fulfill any clinical trials expectations. Detailed emphasis has been allotted, not only to the development of innovative operational structures and processes, but to the corporate alliances with other specialized organizations on matters that further ease the inclusion of Hispanics in clinical trials, such as linguistic and logistics services.
If your organization is interested in improving Hispanic participation in clinical trials, within a Hispanic environment, and with fully United States Board-Certified Hispanic specialist and subspecialist physicians, consider collaborating with us for a physician-based, patient-centered experience. You are welcome to learn more about our current and upcoming clinical trials affairs at http://www.insitu.global/clinical-affairs.html.
No updates found .